Business Context and Reporting Period
Company: Meshflow Acquisition Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: December 11, 2025
Event: Consummation of Initial Public Offering (IPO) and Private Placement.
Key Financial Metrics
| Metric | Value |
|---|---|
| IPO Gross Proceeds | $345,000,000 |
| Private Placement Proceeds | $8,000,000 |
| Total Funds in Trust Account | $345,000,000 |
| Units Sold (IPO) | 34,500,000 (including 4,500,000 from over-allotment) |
| Price Per Unit | $10.00 |
| Private Placement Warrants Sold | 5,333,333 |
| Price Per Private Warrant | $1.50 |
| Deferred Underwriting Commission | Up to $14,700,000 |
Note: Revenue, profit, cash flow, and operating margins are not applicable as this is a pre-operational SPAC filing. The filing does not provide specific debt figures beyond the deferred commission obligation.
Material Changes
This filing represents the initial capitalization of the Company. There is no prior comparable period for operational metrics. The primary material change is the transition from a private entity to a public company with $345,000,000 held in a trust account.
Outlook, Risks, and Unusual Items
- Capital Structure: Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Whole warrants are exercisable at $11.50 per share.
- Trust Account: Proceeds are held in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company.
- Private Placement Allocation: The Sponsor purchased 3,333,333 Private Placement Warrants, while the Underwriters (Cantor Fitzgerald & Co. and Odeon Capital Group, LLC) purchased 2,000,000.
- Financial Statements: An audited balance sheet as of December 11, 2025, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the full terms of the deferred underwriting commission ($14,700,000) and conditions for payment.
- Review the audited balance sheet (Exhibit 99.1) to confirm the exact cash balance and initial working capital.
- Confirm the specific redemption rights and warrant exercise conditions detailed in the final prospectus.
- Monitor the timeline for the Company to identify and consummate a business combination.